New method of microwave thermokeratoplasty to correct myopia in 33 eyes: One-year results

dc.authorid0000-0001-8197-2458
dc.authorid0000-0001-5435-075X
dc.authorid0000-0002-4161-0919
dc.contributor.authorCelik, Ugur
dc.contributor.authorAlagoz, Nese
dc.contributor.authorYildirim, Yusuf
dc.contributor.authorAğca, Alper
dc.contributor.authorMarshall, John
dc.contributor.authorMuller, David
dc.contributor.authorDemirok, Ahmet
dc.date.accessioned2025-05-10T19:50:06Z
dc.date.issued2013
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractPURPOSE: To assess the safety, predictability, and stability of a new microwave thermokeratoplasty procedure to correct myopia. SETTING: Cornea and refractive surgery subspecialty. DESIGN: Prospective clinical trial. METHOD: Thermokeratoplasty was performed in myopic eyes at a single center in Turkey from June 2009 to June 2010. The attempted corrections ranged from -1.25 to -5.75 diopters (D). The main outcome measures were changes in logMAR uncorrected distance visual acuity (UDVA) and in keratometry (K) values. RESULTS: The procedure was performed in 33 eyes (patients aged 20 to 45 years). The mean preoperative logMAR UDVA (0.76 +/- 0.24 [SD]) significantly improved to 0.19 +/- 0.20 at 1 month, postoperatively. By 3 months, the mean UDVA had markedly regressed to 0.59 +/- 0.29; however, the residual improvement remained statistically significant. At 12 months, the mean logMAR UDVA was 0.72 +/- 0.26. The mean K values were 43.9 +/- 1.36 D preoperatively, 41.25 +/- 2.63 D at 1 month, 43.4 +/- 1.69 D at 3 months, and 44.1 +/- 1.09 D at 12 months. The mean endothelial cell density was 2836 +/- 342 cells/mm(2) preoperatively and were statistically unchanged 12 months postoperatively (2732 +/- 353 cell/mm(2)). No patient lost lines of corrected distance visual acuity by 12 months postoperatively. CONCLUSIONS: The new thermokeratoplasty procedure produced the desired reduction in myopia and improvement in postoperative UDVA 1 month postoperatively without significant side effects. However, early and complete regression shows the need for further development of this technique.
dc.description.sponsorshipAvedro, Inc., Boston, Massachusetts, USA
dc.description.sponsorshipSupported by grants from Avedro, Inc., Boston, Massachusetts, USA.
dc.identifier.doi10.1016/j.jcrs.2012.08.066
dc.identifier.endpage233
dc.identifier.issn0886-3350
dc.identifier.issue2
dc.identifier.pmid23332252
dc.identifier.scopusqualityQ1
dc.identifier.startpage225
dc.identifier.urihttps://doi.org/10.1016/j.jcrs.2012.08.066
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12253
dc.identifier.volume39
dc.identifier.wosWOS:000314625100013
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofJournal of Cataract and Refractive Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectIn-Situ Keratomileusis
dc.subjectCollagen Cross-Linking
dc.subjectLaser Thermal Keratoplasty
dc.subjectPhotorefractive Keratectomy
dc.subjectLong-Term
dc.subjectConductive Keratoplasty
dc.subjectRefractive Surgery
dc.subjectStromal Haze
dc.subjectHyperopia
dc.subjectCornea
dc.titleNew method of microwave thermokeratoplasty to correct myopia in 33 eyes: One-year results
dc.typeArticle

Dosyalar